6 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 22.9% per year over the past 5 years.
Operating margin has expanded, at -48.0% in the latest year.
Financial health
The company holds more cash ($92M) than total debt ($40M).
Total debt has grown slower than revenue (4.7% vs 22.9% per year).
Operating income covered interest expense -7.2× in the latest year, up from -13.4× 5 years ago.
The company is unprofitable; at its current free-cash-flow burn it has roughly 3.1 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$77M
-$38M
86.2%
-48.0%
-$30M
$40M
$92M
2024
$80M
-$52M
85.5%
-63.3%
-$23M
$39M
$120M
2023
$81M
-$56M
85.3%
-70.7%
-$48M
$34M
$138M
2022
$71M
-$86M
82.7%
-117.7%
-$77M
$33M
$185M
2021
$49M
-$63M
82.4%
-105.2%
-$53M
$33M
$261M
2020
$28M
-$35M
66.7%
-116.5%
-$33M
$32M
$62M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$20M
-$13M
86.2%
-63.0%
-$7M
$41M
$85M
Dec '25
$20M
-$4M
87.3%
-18.0%
-$2M
$40M
$92M
Sep '25
$20M
-$8M
86.4%
-39.7%
-$9M
$40M
$92M
Jun '25
$20M
-$12M
84.8%
-59.6%
-$8M
$40M
$102M
Mar '25
$18M
-$14M
86.2%
-79.2%
-$12M
$40M
$109M
Dec '24
$19M
-$12M
86.8%
-62.5%
-$4M
$39M
$120M
Sep '24
$20M
-$11M
83.9%
-55.7%
$311000
$34M
$119M
Jun '24
$21M
-$12M
85.8%
-59.2%
-$10M
$34M
$118M
Mar '24
$19M
-$16M
85.5%
-76.4%
-$10M
$34M
$127M
Dec '23
$19M
-$11M
85.2%
-59.3%
-$7M
$34M
$138M
Sep '23
$20M
-$13M
86.6%
-67.0%
-$10M
$34M
$145M
Jun '23
$23M
-$15M
85.6%
-64.7%
-$14M
$34M
$155M
Mar '23
$19M
-$17M
83.8%
-93.3%
-$18M
$33M
$167M
Dec '22
$21M
-$17M
82.2%
-83.0%
-$16M
$33M
$185M
Sep '22
$19M
-$22M
84.3%
-117.0%
-$20M
$33M
$200M
Jun '22
$17M
-$24M
84.1%
-132.7%
-$19M
$33M
$220M
Mar '22
$15M
-$23M
79.6%
-149.1%
-$22M
$33M
$239M
Dec '21
$15M
-$16M
86.8%
-100.2%
-$11M
$33M
$261M
Sep '21
$13M
-$17M
84.3%
-107.1%
-$17M
$32M
$271M
Jun '21
$13M
-$18M
81.6%
-88.4%
-$13M
$32M
$36M
Valuation over time
How the market has priced SGHT against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 6.7× (Mar '23) to 3.8× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is SGHT growing its revenue and profit?
Over the past 5 years, Sight Sciences, Inc.'s revenue has grown 22.9% per year. These are computed facts, not advice.
How much debt does SGHT have?
As of FY2025, Sight Sciences, Inc. reported $40M of total debt against $92M of cash; operating income covered interest expense -7.2×.
What is SGHT's profit margin?
In FY2025, gross margin was 86.2%, operating margin -48.0%, and net margin -49.7%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.